Plunkett Research Online: Palatin Technologies Inc

PALATIN TECHNOLOGIES INC (PTN:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the me.....



Palatin Technologies Inc
Ticker: PTN
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 609 495-2200
Fax: 609 495-2201
Address: 4B Cedar Brook Drive
Cranbury, NJ 08512 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Diversified
Sexual Dysfunction Drugs
Inflammation Drugs
Peptide Technology
Diagnostic Imaging Products
Obesity Treatments
Contacts Description
Carl SpanaCEO/Co-Founder/Director/President
Stephen WillsCFO/Chief Accounting Officer/COO/Executive VP/Secretary/Treasurer
See More
Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the me.....See More See More

Auditor: KPMG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Vyleesi
PL9643
PL8177
PL3994
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: